- Healthcare Professionals
- Healthcare Professionals
Welcome to Arkis BioSciences®, where we are passionate about patient care and bringing about healing through state-of-the-art medical technology. Arkis develops surgical instrumentation that is designed to be less invasive, reduce trauma, and potentially reduce surgical duration. Arkis provides the following product information and resources to assist hydrocephalus patients and caregivers with staying informed on emerging options for potentially improving hydrocephalus treatments. A hydrocephalus diagnosis is complex, and treatments are individually tailored by the patient’s doctor and medical team who best understand each individual’s unique health situation. If you are interested in discussing Arkis options with your medical team, please provide them the associated product information, and work with your doctor to develop a treatment plan.
Product Offerings to Improve Hydrocephalus Treatment:
Arkis offers surgeons instrumentation options for completing minimally-invasive shunt implantation procedures.
Single Pass Tunneling Guidewire®
For frontally-placed ventriculoperitoneal shunt procedures, the Single Pass Tunneling Guidewire® (combined with our Single Pass® Workflow) commonly reduces the number of surgical incision sites required. The Single Pass Tunneling Guidewire™ may reduce trauma and surgical duration.
The patented guidewire technology as well as the patented Single Pass® workflow allows surgeons the option to reduce the number of surgical sites required to install a frontally-placed VP shunt. Specifically, the surgeon has the option of eliminating the surgical incision site behind the ear, which was previously required to place the shunt valve. This potential reduction in surgical sites translates into a reduced chance for a surgical site infection (SSI), and potential to improve recovery times. In addition, the patented guidewire tip is designed to minimize subcutaneous trauma during shunt lumen placement, potentially resulting in less scar tissue formation.
“The Arkis Single Pass Tunneling Guidewire® is a unique instrument designed to allow passing the shunt catheter from the abdomen to a frontal catheter site-eliminating the need for a neck incision. As such, it should reduce procedure time and possibly lower the incidence of infection since one incision is eliminated.”
– Dr. Marvin Sussman, Former Member, Board of Directors – Hydrocephalus Association Chair, HA NPH and Adult Hydrocephalus Initiative, Arkis BioSciences Clinical Advisory Board Member
To view surgical details of the use of the Single Pass Tunneling Guidewire and the Single Pass Workflow:
For more information or to discuss the potential for use of the Single Pass Tunneling Guidewire with your doctor, download the product brochure.
Product Offerings to Improve Intrathecal Drug Delivery, or “Pain Pump” Installations:
An intrathecal pain pump is one option for treatment of chronic pain, and works by delivering medicine directly into the intrathecal space of the spine. During placement of an intrathecal pain pump, the Arkis Subcutaneous Guidewire can be used for subcutaneously navigating the curvature of the abdomen from the frontal abdominal incision, around the waist and back to the location of the intrathecal catheter in the spine. Surgeons may use it to assist with subcutaneously routing the intrathecally-placed catheter to the frontally-placed drug delivery system. The patented guidewire tip is intended to minimize subcutaneous trauma while during the shunt lumen placement portion of the procedure, potentially resulting in less scar tissue formation.
For more information or to discuss the potential for use of the Subcutaneous Guidewire with your doctor, download the product brochure.
Advancing medical technology worldwide to improve the lives of people suffering from intracranial hypertension.
Address: 1 Momentum Way, Knoxville, TN 37920 | Tel: (844) 247-5383 (toll free)
Arkis BioSciences is ISO 13485:2016 certified for its Medical Device Quality Management System by TUV USA, Inc. (Member of TUV NORD Group).